Product
PegIFN-alpha2a
1 clinical trial
2 indications
Indication
Hepatitis BIndication
ChronicClinical trial
A Phase 2, Open-label, Single-arm, Multicenter Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Treatment With JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Patients With Chronic Hepatitis B Virus InfectionStatus: Completed, Estimated PCD: 2022-05-16